Stock listing
Kowa Co. Ltd.
Selected listing: 49N · FWB · EUR · DE
Kowa Co. Ltd. (Frankfurt:49N), Health Technology. Latest release Apr 6, 2026: K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates…
- Ticker
- Frankfurt:49N
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Frankfurt
- Currency
- EUR
Latest news from Kowa Co. Ltd.
K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates Tumor-Selective Pharmacokinetics, Extensive Intratumoral Distribution and Superior Efficacy in Non-Clinical Animal Models
April 6, 2026
KKR and Taiyo Holdings Agree to Privatization to Accelerate Long-Term Growth
March 31, 2026
Nicox and Kowa Sign Key Agreement worth up to €191.5 million for Exclusive Rights to Glaucoma Treatment NCX 470 in U.S. and all Unlicensed Territories
July 17, 2025